$22.130
+0.606 (+2.74%)收盤時
FMS 資訊
FMS 事件
Fresenius Medical Trading Resumes
Fresenius Medical trading resumes
Fresenius Medical Trading Halted, News Pending
Fresenius Medical trading halted, news pending
Fresenius Medical Appoints Shervin Korangy as CEO
Fresenius Medical announced that Shervin Korangy will become Chief Executive Officer and Chair of the Management Board, effective October 12. The supervisory board unanimously appointed Korangy to succeed Helen Giza, who has served as CEO and Chair of the Management Board for four years. Korangy most recently served as CEO of BVI Medical.
Fresenius Medical Care Launches €1B Share Buyback Program
Fresenius Medical Care announced the launch of the first tranche of its new share buyback program with a total volume of around EUR 1B. The first tranche, amounting up to EUR 600M, was initiated May 28 and is expected to be completed by December 15, 2026.
Fresenius Medical Care Plans €1B Share Buyback
Fresenius Medical Care intends to execute a new share buyback program with a total volume of around EUR 1B. The program shall be executed in tranches over a period of 12 months from its start. It is expected to begin in the near future and only a few weeks after the previous share buyback program was successfully completed on April 30.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。








